EGLE‑1: Oral Jepotidusin for Gonorrhea

Whitney covers the EGLE‑1 trial where high‑dose oral JEPO matched ceftriaxone for urogenital gonorrhea but had notable GI side effects.

Play episode from 01:00:06

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!